Neuren Pharmaceuticals Ltd
ASX:NEU

Watchlist Manager
Neuren Pharmaceuticals Ltd Logo
Neuren Pharmaceuticals Ltd
ASX:NEU
Watchlist
Price: 21.09 AUD -3.26% Market Closed
Updated: May 20, 2024

Neuren Pharmaceuticals Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Neuren Pharmaceuticals Ltd
Cash from Operating Activities Peer Comparison

Comparables:
RCE
MYX
BOT
PBP
C
CU6

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Neuren Pharmaceuticals Ltd
ASX:NEU
Cash from Operating Activities
AU$184.9m
CAGR 3-Years
N/A
CAGR 5-Years
96%
CAGR 10-Years
N/A
Recce Pharmaceuticals Ltd
ASX:RCE
Cash from Operating Activities
AU$3.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Cash from Operating Activities
-AU$42.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Cash from Operating Activities
-AU$10.1m
CAGR 3-Years
-8%
CAGR 5-Years
0%
CAGR 10-Years
-29%
Probiotec Ltd
ASX:PBP
Cash from Operating Activities
AU$15.7m
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
9%
C
Clarity Pharmaceuticals Ltd
ASX:CU6
Cash from Operating Activities
-AU$27.5m
CAGR 3-Years
-59%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Neuren Pharmaceuticals Ltd's Cash from Operating Activities?
Cash from Operating Activities
184.9m AUD

Based on the financial report for Dec 31, 2023, Neuren Pharmaceuticals Ltd's Cash from Operating Activities amounts to 184.9m AUD.

What is Neuren Pharmaceuticals Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
96%

Over the last year, the Cash from Operating Activities growth was 5 038%.